King International Investment Limited (HKG:0928)
0.0800
+0.0020 (2.56%)
May 27, 2025, 3:49 PM HKT
King International Investment Company Description
King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong.
The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business.
The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services.
The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023.
King International Investment Limited was incorporated in 2001 and is based in Central, Hong Kong.
King International Investment Limited
Country | Cayman Islands |
Founded | 2001 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 13 |
CEO | Ming Yan |
Contact Details
Address: Gloucester Tower Central Hong Kong | |
Website | kinginternational.hk |
Stock Details
Ticker Symbol | 0928 |
Exchange | Hong Kong Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | HKD |
ISIN Number | KYG5924H1231 |
SIC Code | 5600 |
Key Executives
Name | Position |
---|---|
Wai Lun Man | Executive Director |
Mengyao Wang | Executive Director |
Yueyingtan Leng | Chairman |
Ka Sing Wong | Company Secretary |